Language selection

Search

Details for: AURO-OLANZAPINE ODT

Company: AURO PHARMA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02448726AURO-OLANZAPINE ODTOLANZAPINE5 MGTABLET (ORALLY DISINTEGRATING)ORAL
02448734AURO-OLANZAPINE ODTOLANZAPINE10 MGTABLET (ORALLY DISINTEGRATING)ORAL
02448742AURO-OLANZAPINE ODTOLANZAPINE15 MGTABLET (ORALLY DISINTEGRATING)ORAL
02448750AURO-OLANZAPINE ODTOLANZAPINE20 MGTABLET (ORALLY DISINTEGRATING)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: